Power plants are engineered with precision down to the smallest detail, yet one critical variable is often considered too ...

MSD has decided to abandon the development of its anti-TIGIT antibody vibostolimab and anti-LAG-3 antibody favezelimab, blowing a hole in its immuno-oncology pipeline. The demise of the two programmes ...

MSD has announced a takeover deal for Cidara Therapeutics, an infectious disease specialist currently focused on developing a preventive antibody-based therapy for influenza. The agreement – first ...

FFD POWER’s 800V BESS solutions are typically deployed as AC-coupled, low-voltage systems. LFP battery racks are connected on the DC side to bidirectional Power Conversion Systems (PCS), which output ...